Clinical Trial Update: A Classroom Study to Assess the Time of Onset of Vyvanse (Lisdexamfetamine Dimesylate) in Pediatric Subjects Aged 6-12 With Attention Deficit/Hyperactivity Disorder (ADHD) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing time of onset of Vyvanse (lisdexamfetamine dimesylate) in children aged 6-12 with ADHD; study completed with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Vyvanse (lisdexamfetamine dimesylate)

Snippet

Sponsor: Shire | Conditions: ADHD | Phase 3 | Status: COMPLETED | Results posted: 2009-06-05